Abstract
The experimental evidence from the last decade made telomerase a prominent member of a family of moonlighting proteins performing different functions at various cellular loci. However, the study of extratelomeric function(s) of the catalytic subunit of mammalian telomerase (TERT) is often complicated by the fact that it is sometimes difficult to distinguish them from its role(s) at chromosomal ends. Here we describe an experimental model for studying extranuclear function(s) of mammalian telomerase in the yeast Saccharomyces cerevisiae. We demonstrate that the catalytic subunit of mammalian telomerase protects the yeast cells against oxidative stress and affect the stability of mitochondrial genome. The advantage of using S. cerevisiae for the study of mammalian telomerase is that (i) mammalian TERT does not interfere with its yeast counterpart in the maintenance of telomeres, (ii) yeast telomerase is not localized in mitochondria and (iii) it does not seem to be involved in the protection of the cells against oxidative stress and in the stabilization of mtDNA. Thus yeast cells can be used as a ‘test tube’ for reconstitution of mammalian TERT extranuclear function(s).
Keywords: telomerase, mitochondria, yeast, oxidative stress
Introduction
Telomerase is one of the most fascinating enzymes involved in DNA replication. It carries its own RNA template (TR) and by employing an RNA-dependent DNA polymerase activity of its protein catalytic subunit (telomerase reverse transcriptase, TERT) it extends 3′ single stranded overhangs present at the termini of nuclear chromosomes thus preventing the shortening of DNA due to the end-replication problem (Blackburn 2010). Besides its major role in telomere maintenance, telomerase is also involved in cellular processes not associated with these specialized nucleoprotein structures at the ends of linear chromosomes (for review see (Chung et al. 2005; Bollmann 2008; Majerska et al. 2011; Chiodi and Mondello 2012; Ding et al. 2013; Saretzki 2014; Li and Tergaonkar 2014; Jaiswal et al. 2013; Sung et al. 2014)). Telomerase was shown to be involved in the control of genes whose products participate in cell cycle, cell signaling, metabolism and apoptosis (Xiang et al. 2002; Smith et al. 2003; Perrault et al. 2005; Rahman et al. 2005; Choi et al. 2008; Yang et al. 2008; Park et al. 2009; Wege et al. 2011; Shkreli et al. 2012; Iannilli et al. 2013; Listerman et al. 2013), repair of DNA double-strand breaks (Shin et al. 2004), DNA damage response (Masutomi et al. 2005; Singhapol et al. 2013), chromatin remodeling (Maida et al. 2014), multidrug resistance phenotype (Ling et al. 2012) and cell reprogramming (Kinoshita et al. 2014). Interestingly, some of the extratelomeric activities of telomerase are performed in mammalian mitochondria (for review see (Saretzki 2009; Gordon and Santos 2010; Ale-Agha et al. 2014)). For example, TERT associates with an RNA subunit of mitochondrial RNA-processing endoribonuclease forming an RMRP complex (RNA component of mitochondrial RNA processing endoribonuclease) possibly involved in the regulation of gene expression (Maida et al. 2009). In addition, mitochondrial TERT can act as a TR-independent reverse transcriptase and is associated with several organellar transfer RNAs in vivo (Sharma et al. 2012). Importantly, while under normal conditions only about 10-20% of TERT is present in mitochondria, in cells exposed to oxidative stress almost 80% of the protein localizes in these organelles (Haendeler et al. 2003; Haendeler et al. 2004; Santos et al. 2004; Santos et al. 2006; Ahmed et al. 2008; Singhapol et al. 2013). Mammalian TERT contains a putative mitochondrial targeting sequence (MTS) (Santos et al. 2004) as well as nuclear export signal (Seimiya et al. 2000) that seem to be required for the re-localization of the protein from nucleus to mitochondria in cells exposed to oxidative stress (Kovalenko et al. 2010). In addition to the regulated protein transport, mitochondrially localized TERT is regulated by phosphorylation catalyzed by the protein tyrosine kinase Src(Buchner et al. 2010). However, mitochondrial role(s) of TERT in stressed cells are not clear. It was shown that the protein binds to defined regions of mitochondrial DNA (mtDNA), but as it is not associated with the RNA component of telomerase (Haendeler et al. 2009; Sharma et al. 2012), its role in mtDNA metabolism is therefore apparently different from that played at telomeres. Furthermore, there are contradictory results on the effect of the mitochondrial TERT on mtDNA stability. On one hand, there is an evidence indicating that the re-localization of TERT to mitochondria sensitizes mtDNA to oxidative damage resulting in apoptosis (Santos et al. 2004; Santos et al. 2006). On the other hand, other experimental data demonstrate that TERT protects mtDNA against oxidative damage (Ahmed et al. 2008; Haendeler et al. 2009). The protective role of mitochondrial TERT is in agreement with an observation that cells expressing TERT lacking nuclear export sequence are more sensitive to reactive oxygen species (ROS; Kovalenko et al. 2010). Similarly, cells with a mutant form of TERT unable to enter mitochondria due to an absence of MTS exhibit various mitochondrial dysfunctions (Sharma et al. 2012). How TERT affects mitochondria is a matter of debate. The possibilities include effects on respiratory chain (Ahmed et al. 2008; Haendeler et al. 2009), enhancement of antioxidant defense system (Indran et al. 2011), binding and protection of mtDNA(Haendeler et al. 2009), participation in mtDNA repair (Haendeler et al. 2009; Sharma et al. 2012) and mtDNA replication (Haendeler et al. 2009; Maida et al. 2009; Mukherjee et al. 2011; Sahin et al. 2011; Sharma et al. 2012). In general, elucidation of the mechanism might provide new insights on anti-telomerase therapy of diseases associated with telomerase-positive cells.
With the aim to develop a simple experimental system for addressing the above questions, we expressed mammalian TERT in the yeast Saccharomyces cerevisiae. In contrast to mouse or human TERT, yeast protein subunit of telomerase (encoded by the gene EST2) does not contain MTS (Santos et al. 2004) and is not associated with mitochondria (Sickmann et al. 2003). At the same time, the expression of mammalian TERT in yeast should not interfere with the maintenance of nuclear telomeres, as it is unable to form a functional complex with the RNA subunit of yeast telomerase (Bah et al. 2004). Thus, if targeted to yeast mitochondria, we should be able to assess mitochondria-specific function(s) of mammalian TERT. We reasoned that if we were able to recapitulate the effect(s) of TERT on yeast mitochondria similar to those observed in mammalian cells, S. cerevisiae might become a suitable in vivo test tube for tackling questions related to the mitochondrial functions of telomerase in higher eukaryotes.
Materials and Methods
Microbial strains and growth conditions
S. cerevisiae W303-1A (MATa ade2-1; ura3-1; his3-15; trp1-1; leu2-3,1,2; can 1-10) was used in most of the experiments. The strains BY4741 (MATa; his3Δ0; leu2Δ0; met15Δ0; ura3Δ0)and YLR318W_BY4741(Δest2) (MATa; his3Δ0; leu2Δ0; met15Δ0; ura3Δ0; est2Δ) from the EUROSCARF library of deletion mutants were employed in the experiment described in Fig. S1. For routine purposes yeast cultures were grown at 28°C in a complex medium (1% (w/v) yeast extract, 2% (w/v) bacto-peptone) supplemented with the corresponding carbon source (2% (w/v) glucose (YPD) or 3% (v/v) glycerol plus 0.05% (w/v) glucose (YPDG)). Alternatively, synthetic medium (0.17% (w/v) yeast nitrogen base without amino acids and ammonium sulfate, 0.5% (w/v) ammonium sulfate) supplemented with appropriate amino acids, bases and corresponding carbon source (2% (w/v) glucose (SD), or 2% (w/v) galactose (SGal)) was used. To induce the expression of genes that were cloned under the GAL1 promoter (PGAL1) into the pYES2/CT plasmid (Life Technologies), the cells were grown overnight at 28°C with shaking (225 rpm) in 5 ml of SD medium, then diluted to 4×106 cells/ml into either SD (repressible conditions), or SGal (inducible conditions) medium and cultivated for 20 h at 28°C with shaking. The cells were subsequently washed with water and diluted to 5×106cells/ml in 1× phosphate-buffered saline (PBS). To induce oxidative stress menadione was added to a final concentration of 65 mM (SGal) or 100 mM (SD), followed by incubation for 1 h at 28°C with shaking. 10-fold dilutions were then spotted on solid media as indicated and cultivated at 28°C. For ethidium bromide (EtBr) treatment, the cells were pre-cultivated as above and diluted to 1×106 cells/ml in SD medium. EtBr was added to a final concentration of 25 μM of EtBrfollowed by incubationfor 8 h at 28°C. The cells were then spread on solid YPDG media and incubated at 28°C for 3-5 days. Respiratory-deficient cells were distinguished from wild-type cells by colony size (petite vs. grande) as well as using 2,3,5-triphenyltetrazolium chloride (TTC) test(Ogur et al. 1957). The differences in the frequency of petite colonies were statistically evaluated using unpaired Student's t-Test by the Microsoft Excel 2010 T.TEST function. P values < 0.05 were considered significant. Transformation of S. cerevisiae was done as described by (Gietz et al. 1995). Escherichia coli DH5α (F-, φ80dlacZΔM15, Δ(lacZYA-argF) U169, deoR, recA1, endA1, hsdR17 (rk-, mk+), λ, thi-1, gyrA96, relA1, glnV44, nupG) was used for the amplification of plasmid constructs. Bacterial cultures were grown in LB medium (1% (w/v) bacto-peptone, 0.5% (w/v) yeast extract, 1% (w/v) NaCl, pH 7.5) containing 100 μg/ml ampicillin. Plasmids were introduced into E. coli cells by electroporation (Green and Sambrook 2012).
Manipulations with nucleic acids
Isolation of DNA and RNA, restriction enzyme analysis, DNA (de)phosphorylation and ligation, polymerase chain reactions, agarose gel electrophoresis, extraction of DNA from agarose gels, transfer to Nylon membranes and DNA hybridization were performed according to standard protocols (Green and Sambrook 2012) or based on the procedures recommended by suppliers of the corresponding enzymes and kits.For detection of expression of TERT-encoding gene in S. cerevisiae, total RNA was treated with DNase I and reverse-transcribed into cDNA using Maxima H Minus First Strand cDNA Synthesis Kit (Thermo Scientific). The presence of mt-mTERT transcript and contamination of the samples by plasmid DNA was assessed using the primers mTERT-rtPCR-f and mTERT-rtPCR-r (sequences of all oligonucleotides are listed in Table S1) yielding a PCR fragment of 1,139 bp(Nozawa et al. 2001). The degree of contamination of the samples by genomic DNA was assessed by the primers ACT1_up2 and ACT1_down2, resulting in 117 bpfragment in case of cDNA and 426 bp fragment in case of genomic DNA. Quantitative RT-PCR (qRT-PCR) was performed on cDNA prepared as described above using Luminaris Color HiGreen High ROX qPCR Master Mix (Thermo Scientific) and primers mTERT_qpcr_f + mTERT_qpcr_r (for mTERT; Flores et al. 2006) or ACT1_rt-pcr_f + ACT1_rt-pcr_r (for ACT1; Taylor et al. 2005) and conducted with StepOne cycler (ApplideBiosystems). The relative amount of RNA was determined using the method of relative standard curve method described by Livak (1997). ACT1 mRNA was used for normalization of gene expression.The differences in the relative mt-mTERT levels between cells pre-grown in SD and SGal media were statistically evaluated using Student's t-Test by the Microsoft Excel 2010 T.TEST function. P values < 0.05 were considered significant (*).
Construction of plasmids
For the gene encoding FOXC2 (www.ncbi.nlm.nih.gov/nuccore/AF124843) we first needed to replace 12 TGA triplets (decoded as tryptophan in Fusariumoxysporum mitochondria) to TGG employed by a tryptophan codon by cytosolic ribosomes in S. cerevisiae. In addition, we (i) optimized the codon composition for expression of the gene in S. cerevisiae, (ii)placed a sequence encoding an N-terminal mitochondrial targeting signal (MTS) from subunit 9 of the FO-ATPase (Su9) of Neurosporacrassa(Westermann and Neupert 2000) at 5′ end of the open reading frame (ORF), and (iii) placed a BssHII recognition site between MTS and FOXC2. Such engineered gene (GenBank accession numberKP272109) harboring recognition sites for endonucleases HindIII and EcoRI at its 5′ and 3′ end, respectively, has been synthesized by MWG Operon and placed into the SmaI site of pBluescript II SK(+). The HindIII-EcoRI fragment carrying FOXC2 with MTS (mt-FOXC2) was cloned into the pYES2/CT linearized with the same restriction enzymes yielding pYES2/CT-mt-FOXC2. For construction of pYES2/CT-mt-mTERT carrying mouse TERT (mTERT) with MTS, pYES2/CT-mt-FOXC2 was digested with BssHII and EcoRI and the DNA fragment carrying mt-FOXC2 was replaced (in frame with MTS) by a PCR fragment representingmTERT amplified from pGRN188 plasmid containing mTERTcDNA ((Greenberg et al. 1999); kindly provided by Ronald A. DePinho, The University of Texas, USA) using the primers mTERT-mtpYES-F and mTERT-mtpYES-R. Mouse TERT lacking MTS-coding sequence amplified from pGRN188 using primers mTERT-pYES-F and mTERT-mtpYES-R was cloned into pYES2/CT-Su9 digested with BssHII and EcoRI resulting in pYES2/CT-mTERT. The plasmid pUG35-mTERT_yEGFP3 was prepared by inserting the PCR fragment carrying mTERT amplified from pGRN188 using the primers mTERT_up and mTERT_dn_noSTOP in to the SmaI site of pUG35-yEGFP3 ((Niedenthal et al. 1996) provided by Johannes H. Hegemann (Heinrich-Heine-Universität, Düsseldorf, Germany)). For all plasmid constructs, the regions containing the inserted DNA were verified by DNA sequencing (Macrogen, South Korea).
Fluorescence microscopy
S. cerevisiae strain W303-1A carrying pUG35_yEGFP3 or pUG35_mTERT_yEGFP3,was grown overnight in 5 ml of SD media, then inoculated into a fresh SD to a final concentration of 5×106 cells/ml and cultivated for another 3 h. Cells were then washed with 1× PBS, resuspended in the same buffer and incubated for 30 min at room temperature in the presence of 0.5 μg/ml of 4′,6-diamidino-2-phenylindole (DAPI). 5 μl of the cell suspension was inspected using Zeiss Spinning Disc (Zeiss) microscope.
Results
Regulated expression of mitochondrially targeted mammalian TERT in S. cerevisiae
Before investigating effects of expression of mouse TERT (mTERT) we tested if the yeast catalytic subunit of telomerase Est2p does not affect cellular sensitivity to oxidative stress. We compared the growth of wild-type and Δest2 mutant cells after the treatment with H2O2 and observed similar sensitivity to this agent in both strains (Fig. S1). This result together with the fact that Est2p lacks MTS (Santos et al. 2004) and is not associated with purified S. cerevisiae mitochondria (Sickmann et al. 2003) indicates that yeast telomerase does not play a role in protecting mitochondria against oxidative damage. To express mTERT in S. cerevisiae and ensure its mitochondrial localization, we constructed a plasmid pYES2/CT-mt-mTERT carrying an ORF for mTERT fused with the first 69 amino acids of the N. crassa Su9 that is used to target heterologously expressed proteins into S. cerevisiae mitochondria (Westermann and Neupert 2000). The fusion gene was placed under PGAL1 promoter (Fig. 1A) enabling its conditional expression in the cells grown in SGal media containing 2% galactose. The expression of mt-mTERT in SGal media was verified by RT-PCR analysis (Fig. 1B). To obtain quantitative data on the expression of mt-mTERT under repressible and inducible conditions, we performed qRT-PCR analysis and found that the levels of mt-mTERT RNA is nearly 50-fold higher in cells grown on galactose compared with cells cultivated on glucose (Fig. 1C). Next, we investigated, if heterologously expressed mTERT is targeted to yeast mitochondria. We expressed the protein in fusion with yEGFP3 at C-terminus and assessed its subcellular localization. Indeed, when inspected by fluorescence microscopy, we observeddistinct mTERT-GFP foci. Although we cannot exclude a possibility that some of these foci are represented by mTERT-GFP aggregates, their co-localization with mitochondria stained with DNA-intercalating dye DAPI indicates that the fusion protein is present mostly in the organelles (Fig. 2).
Figure 1. Heterologousproduction of mTERT in S. cerevisiae using galactose-induced expression.

(A) Scheme of the region of the expression plasmid encoding recombinant reverse transcriptases used in this study. PGAL1, GAL1 promoter; MTS, N-terminal mitochondrial targeting signal (MTS) from subunit 9 of the FO-ATPase (Su9) of Neurosporacrassa; TCYC1, CYC1 terminator.(B) The expression of mt-mTERT coding gene was tested by RT-PCR using the primers mTERT-rtPCR-f and mTERT-rtPCR-r (mTERT primers) and the level of contamination by genomic DNA was assayed using the primers ACT1_up2 and ACT1_down2 (ACT1 primers). Specified are expected lengths of the PCR products. C, cells transformed with the control pYES2/CT plasmid. (C) Quantitative RT-PCR analysis of RNA isolated from cells grown in glucose (SD, repressible conditions) and galactose (SGal, inducible conditions) media was performed as described in Materials and Methods. Presented are results of three technical replicates.Bars represent standard errors of means (SEM). The differences in the relative mt-mTERT levels between cells pre-grown in SD and SGal media were statistically evaluated using Student's t-Test by the Microsoft Excel 2010 T.TEST function. P values < 0.05 were considered significant (*).
Figure 2. Mouse TERT co-localizes with DAPI-stained mitochondria of S. cerevisiae when expressed in fusion with GFP at C-terminus.

C, control cells carrying pUG35-yEGFP3 plasmid.
Mitochondrially targeted mTERT protects S. cerevisiaeagainst oxidative stress
The results indicating that we can conditionally express mTERT and target it to mitochondria of S. cerevisiae enabled us to assess its effect on the yeast cells exposed to oxidative stress. In the preliminary experiments, we observed that the expression of mt-mTERT protected yeast cells against 30 mM H2O2 (Fig. S2). However, we observed some variation in sensitivity of the control cells between the experiments. Namely, the effect of H2O2 treatment of control cells resulted in only a mild decrease of survival in some cases and thus the protective effect of mt-mTERT was not that evident. Therefore, we induced oxidative stress by alternative means and treated the cells with menadione (2-methyl-1,4-naphthoquinone). Menadione isa redox-cycling drug that can be reduced in vivo to semiquinone. This in turn reduces oxygen to superoxide anion radical, regenerating the oxidized quinone thusinducing acute generation of ROS (Hassan and Fridovich 1979; Criddle et al. 2006). We found that whereas S. cerevisiae transformed with an empty vector were sensitive to the drug (Fig. 3A), expression of mt-mTERT protected the cells against menadione (Fig. 3A). This protective effect was largely diminished when mTERT lacked MTS (Fig. 3B). Furthermore, rescuing growth of menadione-treated cells was dependent on the pre-cultivation of the cells carrying pYES2/CT-mt-mTERT in media containing galactose. On the other hand, pre-cultivation in repressible SD media did not result in better growth of the cells carrying the plasmid (Fig. 3C) indicating a dependence of the rescuing effect on the mt-mTERT expression. Importantly, the effect of mt-mTERT on yeast cells exposed to oxidative stress is not accompanied by changes in telomere length (Fig. S3). This implies that, similarly to mammalian cells (Sharma et al. 2012), the mt-mTERT-mediated protection against oxidative damage is independent of its function at nuclear telomeres.
Figure 3. Expression of mitochondrially targetedmTERT in S. cerevisiae protects the cells against oxidative stress.

(A) Cells transformed with a control plasmid pYES2/CT (“C”) or vectors carrying either mtFOXC2 or mt-mTERT were pre-cultivated in SGal (inducible conditions) medium and treated with menadione as described in Materials and Methods. Aliquots from 10-fold serial dilutions were then spotted on SD plates. (B) The same experiment as in (A) was performed with a plasmid carrying mTERT lacking Su9 MTS. (C)Cells transformed with a control plasmid pYES2/CT (“C”) or plasmid carrying mt-mTERT were pre-cultivated in SGal (inducible conditions) or SD (repressible conditions) media and treated with menadione. Aliquots from 10-fold serial dilutions were then spotted on SD plates.
Mitochondrial reverse transcriptase FOXC2 from F. oxysporum also renders S. cerevisiae resistant to oxidative stress
Next, we investigated, if the protective effect on yeast mitochondria is limited to mTERT, or can be mediated by another reverse transcriptase. To address this question we engineered a gene for FOXC2, a reverse transcriptase encoded by a mitochondrial plasmid of F. oxysporum(Galligan et al. 2011; Walther and Kennell 1999). We found that, similarly to mammalian TERT, expression of mt-FOXC2 in S. cerevisiae increased their resistance to both menadione and H2O2 (Fig. 3A and Fig. S2). These results demonstrate that presence of TERT and FOXC2 is beneficial for cells exposed to oxidative stress and indicate that it might be a general feature of mitochondrially localized reverse transcriptases.
Expression of TERT in S. cerevisiae affects the stability of mitochondrial DNA
S. cerevisiae is a facultative anaerobic petite-positive yeast species thus allowing testing the effect of TERT expression on the stability of mtDNA. Cells lacking a part or entire mtDNA molecule are able to grow on glucose (where they form small (petite) colonies), whereas they lose the ability to grow on nonfermentable carbon source such as glycerol. We observed that the expression of mt-mTERT and mt-FOXC2 harboring Su9 MTS in yeast cells significantly increases the frequency of spontaneously formed petite colonies (Fig. 4A). This effect was not observed in the case of mTERT without the Su9 MTS (Fig. 4A). On the other hand, expression of mt-mTERT and mt-FOXC2 in cells exposed to EtBr reduced the frequency of respiratory-deficient mutants compared with the EtBr-treated cells lacking TERT (Fig. 4B). Conversely, a presence of mTERT without Su9 MTS did not affect the frequency of EtBr-induced petite mutants (Fig. 4B). Although it is difficult to explain these apparently conflicting effects of TERT on stability of mitochondrial genome it is clear that it directly or indirectly interacts with mtDNA and affects its replication, recombination and/or segregation.
Figure 4. Mitochondrially localized mTERT and FOXC2 affect the stability of yeast mitochondrial genome.

To induce the expression of the cloned genes, cell cultures were grown in SGal medium for 20 h followed by treatment without (A) or with (B) 25 μMEtBr for 8 h at 28°C as described in Materials and Methods. The cells were then spread on YPDG medium and after 3-5 days of cultivation at 28°C respiratory-deficient cells were distinguished from wild-type cells by colony size (petite vs. grande) as well as using TTC overlay test (Ogur et al. 1957). Presented are results of three independent experiments. Bars represent standard errors of means (SEM). The differences in the frequency of petite colonies were statistically evaluated using unpaired Student's t-Test by the Microsoft Excel 2010 T.TEST function. P values < 0.05 were considered significant (*).
Discussion
There is a growing number of so called moonlighting proteins performing different functions at various cellular loci (Huberts and van der Klei 2010). The experimental evidence from the last decade made telomerase a prominent member of this list. Although extra telomeric functions of mammalian telomerase are investigated for several years, the studies very often report conflicting results. In our paper we established a simpler experimental system allowing the analysis of mitochondrial functions of mammalian TERT in S. cerevisae cells taking advantange of the fact that yeast catalytic subunit of telomerase (Est2p) is not localized in mitochondria and it does not seem to be involved in the protection of the cells against oxidative stress. On one hand it is difficult to envisage that the rest of the machinery involved in TERT-associated oxidative stress response is also present in yeast. On the other hand, this is not necessarily a limitation, because it would enable additions of other mammalian proteins and testing their effect on mTERT-mediated protection of the cells against oxidative stress.For example, similar approach has been successfully employed for reconstitution of Bax-induced cell death in S. cerevisiae taking advantage of the fact that there is no Bax-like protein in yeast (Polcic and Forte 2003).
Our expression system provides advantage of conditional expression of mt-mTERT as demonstrated by qRT-PCR analysis (Fig. 1C). Our attempts to confirm the expression of mt-mTERT on protein level resulted in varying results indicating that the levels of the protein are too low to be reproducibly detected by Western blot using available antibodies (data not shown). This is consistent with the previously published studies on expression of mammalian telomerase in yeast cells (Bah et al. 2004). It is possible that translation of mRNA for mt-mTERT is not efficient enough to result in detectable amount of the protein. Yet the fact that the pre-cultivation of mt-mTERT expressing cells on galactose is required for its protective effect (Fig. 3C) indicates that even a small amount of telomerase can protect S. cerevisiae against oxidative stress.
Both mouse and human TERTs contain an N-terminal MTS that was shown to mediate its localization into mammalian mitochondria (Santos et al. 2004). When expressed in their native forms, at least a fraction of mTERT was shown to co-localize with S. cerevisiae mitochondria (Fig. 2). However, to fully mediate the protective effect on menadione-treated cells, it was important to attach Su9 MTS at N-terminus of the mTERT. It is possible that, given the overall low abundance of heterologously expressed mTERT in S. cerevisiae (see above), its mitochondrial targeting via a more robust MTS enables its mitochondrial accumulation above the threshold concentration needed to protect the organelles against oxidative stress.
Mitochondrially targeted mTERT and FOXC2 had a complex effect on the stability of mitochondrial genome in control and EtBr-treated cells, respectively (Fig. 4). Importantly, the complexity of this effect is similar as that observed in mammalian cell. Namely, Haendeler et al. (2009) showed that human cells containing TERT directed exclusively to mitochondria exhibit an increased resistance to EtBr-induced reduction of mtDNA copy number, which is consistent with our results. These two opposing effects of TERT possibly cause the seemingly contradictory outcomes: (1) destabilization of mtDNA (by direct or indirect means) and (2) decreasing the accessibility of mtDNA to EtBr.At present it is difficult to speculate about potential molecular mechanisms involved in these opposing effects of TERT on the stability of mtDNA. One possibility is based on the observations of Sharma et al (2012), who have shown that mitochondrially localized mammalian TERT binds various mitochondrial RNAs, suggesting that reverse transcriptase activity in the organelle is reconstituted with mitochondrial RNAs. Reversed transcription of mitochondrial RNAs might result in generation of a heterogeneous population of DNA molecules, which may interfere with mtDNA replication machinery thus causing instability of mitochondrial genome. On the other hand, it was shown that RNA converted into DNA by a reverse transcriptase activity could be used to repair DNA double strand breaks (Storici et al. 2007). Therefore, DNA molecules formed from mitochondrial RNAs by telomerase reverse transcriptase might mediate repair of defective mtDNAmolecules generated in EtBr-treated cells. To test this possibility it would be important to investigate, if mutant version of TERT lacking reverse transcriptase activity lose or retain their protective ability. Furthermore, it was shown that binding of EtBr and its derivatives to DNA affects telomerase activity (Koeppel et al. 2001). Hence it is also possible that intercalation of EtBr into mtDNA may affect its interaction with TERT and change its biochemical properties compared to the untreated cells thus resulting in different effects TERT on mtDNA stability in EtBr-treated versus control cells. A complex effect of TERT on stability of mitochondrial genome observed in our experiments also goes in line with conflicting reports demonstrating that re-localization of TERT to mammalian mitochondria can either sensitize (Santos et al. 2004; Santos et al. 2006) or protect (Ahmed et al. 2008; Haendeler et al. 2009) mtDNA against damage. These opposing outcomes are most likely caused by the fact that mitochondrially-targeted TERT may affect multiple events including mtDNA turnover, modulation of mtDNA replication, recombination and repair, processing of DNA double-strand breaks, or alteration of antioxidant defenses (reviewed in Gordon and Santos 2010) and the final effect on mtDNA stability will depend on circumstances specific for the given experimental set-up. Perhaps exploiting the experimental system described in our study will eventually shed more light on the puzzling and contradictory results.
Intriguingly, the protective effect was not limited to mt-mTERT. We observed that the expression and mitochondrial targeting of another reverse transcriptase FOXC2 also renders yeast cells resistant to menadione. As this enzyme is considered to be closely related to telomerase (Walther and Kennell 1999), it would be interesting to test, if other types of reverse transcriptases or DNA-dependent DNA polymerases would have the same effect on mitochondria as telomerase and FOXC2. In our preliminary experiments we employed two isogenic strains of P. kluyveri with or without a mitochondrial plasmid pPK2 encoding DNA polymerase (Blaisonneau et al. 1999) and found that both strains exhibit similar sensitivity to oxidative stress (Fig. S4). Naturally, the reliance of this experiment must be taken with caution as it was carried out in a different organism. Expression of genes encoding various RNA- and DNA-dependent DNA polymerases and their catalytically-deficient versions using our experimental system would be instrumental in addressing the above question. Furthermore, several open reading frames located within mitochondrial group II introns encode reverse transcriptases involved in splicing (Lambowitz and Zimmerly 2011). It is possible that in addition to this primary function, these enzymes may also provide a selective advantage under conditions of oxidative stress. Thus yeast cells can be used as a ‘test tube’ not only for reconstitution of mammalian TERT extranuclear function(s), but also for addressing broader evolutionary questions.
Supplementary Material
Acknowledgments
We thank LadislavKovac for inspiration and continuous support, H. YdeSteensma (Leiden University, The Netherlands) for the S. cerevisiae strain GG595, Johannes H. Hegemann (Heinrich-Heine-Universität, Düsseldorf, Germany) for the plasmid pUG35-yEGFP3, Ronald A. DePinho (University of Texas, USA) for the plasmid pGRN188, JurajKramara (Palacky University in Olomouc, Czech republic) for technical assistance, and Jiri Bartek (Palacky University in Olomouc, Czech republic) for providing the possibility to perform fluorescent microscopy in his laboratory. We also thanktwo anonymous reviewers for their constructive comments, which helped us to improve the manuscript. This work was supported in part by the Slovak grant agencies APVV (0035-11 and 0123-10), VEGA (1/0311/12) and Comenius University(UK/409/2014)and National Institutes of Health Grants 2R01ES013773-06A1.
Footnotes
Conflicts of Interest: The authors declare that there are no conflicts of interest.
References
- Ahmed S, Passos JF, Birket MJ, Beckmann T, Brings S, Peters H, Birch-Machin MA, von Zglinicki T, Saretzki G. Telomerase does not counteract telomere shortening but protects mitochondrial function under oxidative stress. J Cell Sci. 2008;121:1046–1053. doi: 10.1242/jcs.019372. [DOI] [PubMed] [Google Scholar]
- Ale-Agha N, Dyballa-Rukes N, Jakob S, Altschmied J, Haendeler J. Cellular functions of the dual-targeted catalytic subunit of telomerase, telomerase reverse transcriptase--potential role in senescence and aging. Exp Gerontol. 2014;56:189–193. doi: 10.1016/j.exger.2014.02.011. [DOI] [PubMed] [Google Scholar]
- Bah A, Bachand F, Clair E, Autexier C, Wellinger RJ. Humanized telomeres and an attempt to express a functional human telomerase in yeast. Nucleic Acids Res. 2004;32:1917–1927. doi: 10.1093/nar/gkh511. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Blackburn EH. Telomeres and telomerase: the means to the end (Nobel lecture) Angew Chem Int Ed Engl. 2010;49:7405–7421. doi: 10.1002/anie.201002387. [DOI] [PubMed] [Google Scholar]
- Blaisonneau J, Nosek J, Fukuhara H. Linear DNA plasmid pPK2 of Pichia kluyveri: distinction between cytoplasmic and mitochondrial linear plasmids in yeasts. Yeast. 1999;15:781–791. doi: 10.1002/(SICI)1097-0061(19990630)15:9<781::AID-YEA420>3.0.CO;2-0. [DOI] [PubMed] [Google Scholar]
- Bollmann FM. The many faces of telomerase: emerging extratelomeric effects. Bioessays. 2008;30:728–732. doi: 10.1002/bies.20793. [DOI] [PubMed] [Google Scholar]
- Buchner N, Zschauer TC, Lukosz M, Altschmied J, Haendeler J. Downregulation of mitochondrial telomerase reverse transcriptase induced by H2O2 is Src kinase dependent. Exp Gerontol. 2010;45:558–562. doi: 10.1016/j.exger.2010.03.003. [DOI] [PubMed] [Google Scholar]
- Chiodi I, Mondello C. Telomere-independent functions of telomerase in nuclei, cytoplasm, and mitochondria. Front Oncol. 2012;2:133. doi: 10.3389/fonc.2012.00133. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Choi J, Southworth LK, Sarin KY, Venteicher AS, Ma W, Chang W, Cheung P, Jun S, Artandi MK, Shah N, Kim SK, Artandi SE. TERT promotes epithelial proliferation through transcriptional control of a Myc- and Wnt-related developmental program. PLoS Genet. 2008;4:e10. doi: 10.1371/journal.pgen.0040010. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Chung HK, Cheong C, Song J, Lee HW. Extratelomeric functions of telomerase. Curr Mol Med. 2005;5:233–241. doi: 10.2174/1566524053586635. [DOI] [PubMed] [Google Scholar]
- Counter CM, Hahn WC, Wei W, Caddle SD, Beijersbergen RL, Lansdorp PM, Sedivy JM, Weinberg RA. Dissociation among in vitro telomerase activity, telomere maintenance, and cellular immortalization. Proc Natl Acad Sci USA. 1998;95:14723–14728. doi: 10.1073/pnas.95.25.14723. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Criddle DN, Gillies S, Baumgartner-Wilson HK, Jaffar M, Chinje EC, Passmore S, Chvanov M, Barrow S, Gerasimenko OV, Tepikin AV, Sutton R, Petersen OH. Menadione-induced reactive oxygen species generation via redox cycling promotes apoptosis of murine pancreatic acinar cells. J Biol Chem. 2006;281:40485–40492. doi: 10.1074/jbc.M607704200. [DOI] [PubMed] [Google Scholar]
- Ding D, Zhou J, Wang M, Cong YS. Implications of telomere-independent activities of telomerase reverse transcriptase in human cancer. FEBS J. 2013;280:3205–3211. doi: 10.1111/febs.12258. [DOI] [PubMed] [Google Scholar]
- Flores I, Evan G, Blasco MA. Genetic analysis of myc and telomerase interactions in vivo. Mol Cell Biol. 2006;26:6130–6138. doi: 10.1128/MCB.00543-06. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Galligan JT, Marchetti SE, Kennell JC. Reverse transcription of the pFOXC mitochondrial retroplasmids of Fusarium oxysporum is protein primed. Mob DNA. 2011;2:1. doi: 10.1186/1759-8753-2-1. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Gietz RD, Schiestl RH, Willems AR, Woods RA. Studies on the transformation of intact yeast cells by the LiAc/ssDNA/PEG procedure. Yeast. 1995;11:355–360. doi: 10.1002/yea.320110408. [DOI] [PubMed] [Google Scholar]
- Gordon DM, Santos JH. The emerging role of telomerase reverse transcriptase in mitochondrial DNA metabolism. J Nucleic Acids 2010. 2010 doi: 10.4061/2010/390791. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Green MR, Sambrook J. Molecular cloning: a laboratory manual. 4th. Cold Spring Harbor Laboratory Press; Cold Spring Harbor, NY: 2012. [Google Scholar]
- Greenberg RA, O'Hagan RC, Deng H, Xiao Q, Hann SR, Adams RR, Lichtsteiner S, Chin L, Morin GB, DePinho RA. Telomerase reverse transcriptase gene is a direct target of c-Myc but is not functionally equivalent in cellular transformation. Oncogene. 1999;18:1219–1226. doi: 10.1038/sj.onc.1202669. [DOI] [PubMed] [Google Scholar]
- Haendeler J, Drose S, Buchner N, Jakob S, Altschmied J, Goy C, Spyridopoulos I, Zeiher AM, Brandt U, Dimmeler S. Mitochondrial telomerase reverse transcriptase binds to and protects mitochondrial DNA and function from damage. Arterioscler Thromb Vasc Biol. 2009;29:929–935. doi: 10.1161/ATVBAHA.109.185546. [DOI] [PubMed] [Google Scholar]
- Haendeler J, Hoffmann J, Brandes RP, Zeiher AM, Dimmeler S. Hydrogen peroxide triggers nuclear export of telomerase reverse transcriptase via Src kinase family-dependent phosphorylation of tyrosine 707. Mol Cell Biol. 2003;23:4598–4610. doi: 10.1128/MCB.23.13.4598-4610.2003. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Haendeler J, Hoffmann J, Diehl JF, Vasa M, Spyridopoulos I, Zeiher AM, Dimmeler S. Antioxidants inhibit nuclear export of telomerase reverse transcriptase and delay replicative senescence of endothelial cells. Circ Res. 2004;94:768–775. doi: 10.1161/01.RES.0000121104.05977.F3. [DOI] [PubMed] [Google Scholar]
- Hassan HM, Fridovich I. Intracellular production of superoxide radical and of hydrogen peroxide by redox active compounds. Arch Biochem Biophys. 1979;196:385–395. doi: 10.1016/0003-9861(79)90289-3. [DOI] [PubMed] [Google Scholar]
- Huberts DH, van der Klei IJ. Moonlighting proteins: an intriguing mode of multitasking. Biochim Biophys Acta. 2010;1803:520–525. doi: 10.1016/j.bbamcr.2010.01.022. [DOI] [PubMed] [Google Scholar]
- Iannilli F, Zalfa F, Gartner A, Bagni C, Dotti CG. Cytoplasmic TERT associates to RNA granules in fully mature neurons: Role in the translational control of the cell cycle inhibitor p15INK4B. PLoS One. 2013;8:e66602. doi: 10.1371/journal.pone.0066602. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Indran IR, Hande MP, Pervaiz S. hTERT overexpression alleviates intracellular ROS production, improves mitochondrial function, and inhibits ROS-mediated apoptosis in cancer cells. Cancer Res. 2011;71:266–276. doi: 10.1158/0008-5472.CAN-10-1588. [DOI] [PubMed] [Google Scholar]
- Jaiswal RK, Kumar P, Yadava PK. Telomerase and its extracurricular activities. Cell Mol Biol Lett. 2013;18:538–554. doi: 10.2478/s11658-013-0105-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Kinoshita T, Nagamatsu G, Saito S, Takubo K, Horimoto K, Suda T. Telomerase reverse transcriptase has an extratelomeric function in somatic cell reprogramming. J Biol Chem. 2014;289:15776–15787. doi: 10.1074/jbc.M113.536037. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Koeppel F, Riou JF, Laoui A, Mailliet P, Arimondo PB, Labit D, Petitgenet O, Hélène C, Mergny JL. Ethidium derivatives bind to G-quartets, inhibit telomerase and act as fluorescent probes for quadruplexes. Nucleic Acids Res. 2014;29:1087–1096. doi: 10.1093/nar/29.5.1087. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Kovalenko OA, Caron MJ, Ulema P, Medrano C, Thomas AP, Kimura M, Bonini MG, Herbig U, Santos JH. A mutant telomerase defective in nuclear-cytoplasmic shuttling fails to immortalize cells and is associated with mitochondrial dysfunction. Aging Cell. 2010;9:203–219. doi: 10.1111/j.1474-9726.2010.00551.x. [DOI] [PubMed] [Google Scholar]
- Lambowitz A, Zimmerly S. Group II introns: mobile ribozymes that invade DNA. Col Spring Harb Perspect Biol. 2011;3:a003616. doi: 10.1101/cshperspect.a003616. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Li Y, Tergaonkar V. Noncanonical functions of telomerase: implications in telomerase-targeted cancer therapies. Cancer Res. 2014;74:1639–1644. doi: 10.1158/0008-5472.CAN-13-3568. [DOI] [PubMed] [Google Scholar]
- Ling X, Wen L, Zhou Y. Role of mitochondrial translocation of telomerase in hepatocellular carcinoma cells with multidrug resistance. Int J Med Sci. 2012;9:545–554. doi: 10.7150/ijms.4648. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Listerman I, Sun J, Gazzaniga FS, Lukas JL, Blackburn EH. The major reverse transcriptase-incompetent splice variant of the human telomerase protein inhibits telomerase activity but protects from apoptosis. Cancer Res. 2013;73:2817–2828. doi: 10.1158/0008-5472.CAN-12-3082. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Livak K. User Bulletin 2. PE Applied Biosystems; Foster City, CA: 1997. ABI Prism 7700 sequence detection system. [Google Scholar]
- Maida Y, Yasukawa M, Furuuchi M, Lassmann T, Possemato R, Okamoto N, Kasim V, Hayashizaki Y, Hahn WC, Masutomi K. An RNA-dependent RNA polymerase formed by TERT and the RMRP RNA. Nature. 2009;461:230–235. doi: 10.1038/nature08283. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Maida Y, Yasukawa M, Okamoto N, Ohka S, Kinoshita K, Totoki Y, Ito TK, Minamino T, Nakamura H, Yamaguchi S, Shibata T, Masutomi K. Involvement of telomerase reverse transcriptase in heterochromatin maintenance. Mol Cell Biol. 2014;34:1576–1593. doi: 10.1128/MCB.00093-14. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Majerska J, Sykorova E, Fajkus J. Non-telomeric activities of telomerase. Mol Biosyst. 2011;7:1013–1023. doi: 10.1039/c0mb00268b. [DOI] [PubMed] [Google Scholar]
- Masutomi K, Possemato R, Wong JM, Currier JL, Tothova Z, Manola JB, Ganesan S, Lansdorp PM, Collins K, Hahn WC. The telomerase reverse transcriptase regulates chromatin state and DNA damage responses. Proc Natl Acad Sci USA. 2005;102:8222–8227. doi: 10.1073/pnas.0503095102. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Mukherjee S, Firpo EJ, Wang Y, Roberts JM. Separation of telomerase functions by reverse genetics. Proc Natl Acad Sci USA. 2011;108:E1363–71. doi: 10.1073/pnas.1112414108. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Niedenthal RK, Riles L, Johnston M, Hegemann JH. Green fluorescent protein as a marker for gene expression and subcellular localization in budding yeast. Yeast. 1996;12:773–786. doi: 10.1002/(SICI)1097-0061(19960630)12:8%3C773::AID-YEA972%3E3.0.CO;2-L. [DOI] [PubMed] [Google Scholar]
- Nozawa K, Maehara K, Isobe K. Mechanism for the reduction of telomerase expression during muscle cell differentiation. J Biol Chem. 2001;276:22016–22023. doi: 10.1074/jbc.M011181200. [DOI] [PubMed] [Google Scholar]
- Ogur M, John St R, Nagai S. Tetrazolium overlay technique for population studies of respiration deficiency in yeast. Science. 1957;125:928–929. doi: 10.1126/science.125.3254.928. [DOI] [PubMed] [Google Scholar]
- Park JI, Venteicher AS, Hong JY, Choi J, Jun S, Shkreli M, Chang W, Meng Z, Cheung P, Ji H, McLaughlin M, Veenstra TD, Nusse R, McCrea PD, Artandi SE. Telomerase modulates Wnt signalling by association with target gene chromatin. Nature. 2009;460:66–72. doi: 10.1038/nature08137. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Perrault SD, Hornsby PJ, Betts DH. Global gene expression response to telomerase in bovine adrenocortical cells. Biochem Biophys Res Commun. 2005;335:925–936. doi: 10.1016/j.bbrc.2005.07.156. [DOI] [PubMed] [Google Scholar]
- Polcic P, Forte M. Response of yeast to the regulated expression of proteins in the Bcl-2 family. Biochem J. 2003;374:393–402. doi: 10.1042/BJ20030690. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Rahman R, Latonen L, Wiman KG. hTERT antagonizes p53-induced apoptosis independently of telomerase activity. Oncogene. 2005;24:1320–1327. doi: 10.1038/sj.onc.1208232. [DOI] [PubMed] [Google Scholar]
- Sahin E, Colla S, Liesa M, Moslehi J, Muller FL, Guo M, Cooper M, Kotton D, Fabian AJ, Walkey C, Maser RS, Tonon G, Foerster F, Xiong R, Wang YA, Shukla SA, Jaskelioff M, Martin ES, Heffernan TP, Protopopov A, Ivanova E, Mahoney JE, Kost-Alimova M, Perry SR, Bronson R, Liao R, Mulligan R, Shirihai OS, Chin L, DePinho RA. Telomere dysfunction induces metabolic and mitochondrial compromise. Nature. 2011;470:359–365. doi: 10.1038/nature09787. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Santos JH, Meyer JN, Skorvaga M, Annab LA, Van Houten B. Mitochondrial hTERT exacerbates free-radical-mediated mtDNA damage. Aging Cell. 2004;3:399–411. doi: 10.1111/j.1474-9728.2004.00124.x. [DOI] [PubMed] [Google Scholar]
- Santos JH, Meyer JN, Van Houten B. Mitochondrial localization of telomerase as a determinant for hydrogen peroxide-induced mitochondrial DNA damage and apoptosis. Hum Mol Genet. 2006;15:1757–1768. doi: 10.1093/hmg/ddl098. [DOI] [PubMed] [Google Scholar]
- Saretzki G. Telomerase, mitochondria and oxidative stress. Exp Gerontol. 2009;44:485–492. doi: 10.1016/j.exger.2009.05.004. [DOI] [PubMed] [Google Scholar]
- Saretzki G. Extra-telomeric functions of human telomerase: cancer, mitochondria and oxidative stress. Curr Pharm Des. 2014 doi: 10.2174/1381612820666140630095606. [DOI] [PubMed] [Google Scholar]
- Seimiya H, Sawada H, Muramatsu Y, Shimizu M, Ohko K, Yamane K, Tsuruo T. Involvement of 14-3-3 proteins in nuclear localization of telomerase. EMBO J. 2000;19:2652–2661. doi: 10.1093/emboj/19.11.2652. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Sharma NK, Reyes A, Green P, Caron MJ, Bonini MG, Gordon DM, Holt IJ, Santos JH. Human telomerase acts as a hTR-independent reverse transcriptase in mitochondria. Nucleic Acids Res. 2012;40:712–725. doi: 10.1093/nar/gkr758. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Shin KH, Kang MK, Dicterow E, Kameta A, Baluda MA, Park NH. Introduction of human telomerase reverse transcriptase to normal human fibroblasts enhances DNA repair capacity. Clin Cancer Res. 2004;10:2551–2560. doi: 10.1158/1078-0432.ccr-0669-3. [DOI] [PubMed] [Google Scholar]
- Shkreli M, Sarin KY, Pech MF, Papeta N, Chang W, Brockman SA, Cheung P, Lee E, Kuhnert F, Olson JL, Kuo CJ, Gharavi AG, D'Agati VD, Artandi SE. Reversible cell-cycle entry in adult kidney podocytes through regulated control of telomerase and Wnt signaling. Nat Med. 2012;18:111–119. doi: 10.1038/nm.2550. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Sickmann A, Reinders J, Wagner Y, Joppich C, Zahedi R, Meyer HE, Schonfisch B, Perschil I, Chacinska A, Guiard B, Rehling P, Pfanner N, Meisinger C. The proteome of Saccharomyces cerevisiae mitochondria. Proc Natl Acad Sci USA. 2003;100:13207–13212. doi: 10.1073/pnas.2135385100. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Singhapol C, Pal D, Czapiewski R, Porika M, Nelson G, Saretzki GC. Mitochondrial telomerase protects cancer cells from nuclear DNA damage and apoptosis. PLoS One. 2013;8:e52989. doi: 10.1371/journal.pone.0052989. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Smith LL, Coller HA, Roberts JM. Telomerase modulates expression of growth-controlling genes and enhances cell proliferation. Nat Cell Biol. 2003;5:474–479. doi: 10.1038/ncb985. [DOI] [PubMed] [Google Scholar]
- Storici F, Bebenek K, Kunkel TA, Gordenin DA, Resnick MA. RNA-templated DNA repair. Nature. 2007;447:338–341. doi: 10.1038/nature05720. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Sung YH, Ali M, Lee HW. Extracting extra-telomeric phenotypes from telomerase mouse models. Yonsei Med J. 2014;55:1–8. doi: 10.3349/ymj.2014.55.1.1. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Taylor SD, Zhang H, Eaton JS, Rodeheffer MS, Lebedeva MA, O'Rourke TW, Siede W, Shadel GS. The conserved Mec1/Rad53 nuclear checkpoint pathway regulates mitochondrial DNA copy number in Saccharomyces cerevisiae. Mol Cell Biol. 2005;16:3010–3018. doi: 10.1091/mbc.E05-01-0053. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Visacka K, Hofr C, Willcox S, Necasova I, Pavlouskova J, Sepsiova R, Wimmerova M, Simonicova L, Nosek J, Fajkus J, Griffith JD, Tomaska L. Synergism of the two Myb domains of Tay1 protein results in high affinity binding to telomeres. J Biol Chem. 2012;287:32206–32215. doi: 10.1074/jbc.M112.385591. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Walther TC, Kennell JC. Linear mitochondrial plasmids of F. oxysporum are novel, telomere-like retroelements. Mol Cell. 1999;4:229–238. doi: 10.1016/s1097-2765(00)80370-6. [DOI] [PubMed] [Google Scholar]
- Wege H, Heim D, Lutgehetmann M, Dierlamm J, Lohse AW, Brummendorf TH. Forced activation of beta-catenin signaling supports the transformation of hTERT-immortalized human fetal hepatocytes. Mol Cancer Res. 2011;9:1222–1231. doi: 10.1158/1541-7786.MCR-10-0474. [DOI] [PubMed] [Google Scholar]
- Westermann B, Neupert W. Mitochondria-targeted green fluorescent proteins: convenient tools for the study of organelle biogenesis in Saccharomyces cerevisiae. Yeast. 2000;16:1421–1427. doi: 10.1002/1097-0061(200011)16:15<1421::AID-YEA624>3.0.CO;2-U. [DOI] [PubMed] [Google Scholar]
- Xiang H, Wang J, Mao Y, Liu M, Reddy VN, Li DW. Human telomerase accelerates growth of lens epithelial cells through regulation of the genes mediating RB/E2F pathway. Oncogene. 2002;21:3784–3791. doi: 10.1038/sj.onc.1205455. [DOI] [PubMed] [Google Scholar]
- Yang C, Przyborski S, Cooke MJ, Zhang X, Stewart R, Anyfantis G, Atkinson SP, Saretzki G, Armstrong L, Lako M. A key role for telomerase reverse transcriptase unit in modulating human embryonic stem cell proliferation, cell cycle dynamics, and in vitro differentiation. Stem Cells. 2008;26:850–863. doi: 10.1634/stemcells.2007-0677. [DOI] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
